Back to Search
Start Over
PB2276: MAHOGANY: A PHASE 3 TRIAL OF ZANUBRUTINIB PLUS ANTI‐CD20 ANTIBODIES VS LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA.
- Source :
- HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 7
- Database :
- Complementary Index
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 176110459
- Full Text :
- https://doi.org/10.1097/01.HS9.0000975836.58931.97